We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.55B
AUM Growth
-$449M
Cap. Flow
-$417M
Cap. Flow %
-27.01%
Top 10 Hldgs %
47.59%
Holding
143
New
19
Increased
20
Reduced
61
Closed
22

Top Buys

Rank Stock Value
1
CASH icon
Pathward Financial
CASH
+$12.3M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$9.39M
3
COST icon
Costco
COST
+$7.88M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$3.29M
5
CDXS icon
Codexis
CDXS
+$3.09M

Top Sells

Rank Stock Value
1
SNDX icon
Syndax Pharmaceuticals
SNDX
+$28.9M
2
LNW
Light & Wonder
LNW
+$20.6M
3
SMLR
Semler Scientific
SMLR
+$10.3M
4
BBQ
BBQ Holdings, Inc. Common Stock
BBQ
+$9.88M
5
IIII
INSU Acquisition Corp. III Class A Common Stock
IIII
+$9.65M

Sector Composition

Rank Sector Weight
1 Healthcare 28.65%
2 Consumer Discretionary 12.74%
3 Industrials 6.25%
4 Communication Services 4.08%
5 Financials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRM icon
76
CALL
Vroom Inc
VRM
$51.2M
$1.74M 0.11%
18,750
– –
NPCE icon
77
Neuropace
NPCE
$520M
$1.66M 0.11%
443,502
-34,936
-7% -$168K
MACK
78
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.61M 0.1%
429,596
-61,913
-13% -$286K
IDW
79
DELISTED
IDW Media Holdings
IDW
$1.6M 0.1%
1,039,830
-13,022
-1% -$20.2K
KROS icon
80
CALL
Keros Therapeutics
KROS
$210M
$1.58M 0.1%
41,900
– –
PNT
81
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$1.53M 0.1%
+197,783
New +$1.68M
ANEB
82
DELISTED
Anebulo Pharmaceuticals
ANEB
$1.43M 0.09%
+511,073
New +$1.82M
NAUT icon
83
Nautilus Biotechnolgy
NAUT
$112M
$1.39M 0.09%
655,338
-129,460
-16% -$326K
GYRE icon
84
Gyre Therapeutics
GYRE
$701M
$1.29M 0.08%
340,631
-26,823
-7% -$341K
STIM icon
85
Neuronetics
STIM
$213M
$1.21M 0.08%
380,325
-387,075
-50% -$1.41M
AGS
86
DELISTED
PlayAGS
AGS
$1.18M 0.08%
+222,518
New +$1.34M
SLNO
87
DELISTED
Soleno Therapeutics
SLNO
$1.01M 0.07%
604,179
-24,922
-4% -$60.7K
ELTX icon
88
Elicio Therapeutics
ELTX
$79.6M
$981K 0.06%
106,601
-6,499
-6% -$67.9K
ACER
89
DELISTED
Acer Therapeutics Inc
ACER
$968K 0.06%
696,538
-44,472
-6% -$64.4K
ALEC icon
90
Alector
ALEC
$230M
$809K 0.05%
85,514
-6,662
-7% -$72K
HLGN
91
DELISTED
Heliogen, Inc.
HLGN
$807K 0.05%
12,397
– –
LQDA icon
92
Liquidia Corp
LQDA
$7.81B
$799K 0.05%
+146,792
New +$824K
SGRP
93
DELISTED
SPAR Group
SGRP
$781K 0.05%
+538,427
New +$695K
SNDX icon
94
CALL
Syndax Pharmaceuticals
SNDX
$1.8B
$721K 0.05%
+30,000
New +$673K
BACK
95
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$466K 0.03%
40,989
-990
-2% -$21.1K
HYPR icon
96
Hyperfine
HYPR
$99.7M
$448K 0.03%
544,930
– –
LUCD icon
97
Lucid Diagnostics
LUCD
$186M
$438K 0.03%
286,432
-22,546
-7% -$56.1K
IRON icon
98
Disc Medicine
IRON
$3.1B
$423K 0.03%
+8,589
New +$405K
UNCY icon
99
Unicycive Therapeutics
UNCY
$137M
$419K 0.03%
71,054
-1,914
-3% -$14K
XGN icon
100
Exagen
XGN
$168M
$408K 0.03%
150,535
-5,600
-4% -$31.2K
2 3
4
5 6

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return

Nantahala Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Nantahala Capital Management held 143 positions worth $1.55B, down 23% from $1.99B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Nantahala Capital Management withdrew a net $417M in Q3 2022, closing 22 positions and reducing 61 holdings. Its most notable exit was BBQ Holdings, Inc. Common Stock, an estimated $9.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Nantahala Capital Management opened a new position in IDEAYA Biosciences worth $3.78M.

  • Nantahala Capital Management's largest Q3 2022 buy was IDEAYA Biosciences: 253,480 shares worth $3.78M.
  • Nantahala Capital Management added most to Pathward Financial in Q3 2022, an estimated $12.3M increase.
  • Nantahala Capital Management's biggest Q3 2022 reduction was Syndax Pharmaceuticals, cutting an estimated $28.9M.
  • Nantahala Capital Management fully exited BBQ Holdings, Inc. Common Stock in Q3 2022, selling an estimated $9.88M.
  • Nantahala Capital Management's ten largest holdings make up 48% of its $1.55B portfolio in Q3 2022.
  • Nantahala Capital Management opened 19 new positions and closed 22 in Q3 2022.
  • Nantahala Capital Management's portfolio value fell 23% quarter-over-quarter to $1.55B.

Based on Nantahala Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.